Healthcare Global Enterprises
Healthcare Global Enterprises (HCG), headquartered in India, is a leading player in the oncology and healthcare sector. Established in 2001, HCG has made significant strides in providing comprehensive cancer care, with a network of hospitals and clinics across major operational regions in India and beyond. HCG is renowned for its advanced cancer treatment services, including radiation therapy, chemotherapy, and surgical oncology, distinguished by its commitment to personalised patient care and cutting-edge technology. The company has achieved notable milestones, such as being the first to introduce a dedicated cancer hospital in India, solidifying its position as a pioneer in the industry. With a focus on innovation and excellence, HCG continues to enhance its market position, recognised for its high standards of care and successful patient outcomes.
DitchCarbon Score
How does Healthcare Global Enterprises's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Healthcare Global Enterprises's score of 13 is higher than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Healthcare Global Enterprises's reported carbon emissions
In 2024, Healthcare Global Enterprises reported significant carbon emissions, with Scope 1 emissions at approximately 981,240 kg CO2e and Scope 2 emissions at about 34,088,950 kg CO2e. However, the company did not disclose any Scope 3 emissions for this year. In 2023, the emissions figures were notably higher, with Scope 1 emissions remaining constant at about 2,929,130 kg CO2e and Scope 2 emissions at approximately 21,769,000 kg CO2e. The Scope 3 emissions for 2023 were reported at a staggering 6,800,000,000 kg CO2e, indicating a substantial impact from indirect emissions. Despite these figures, Healthcare Global Enterprises has not set specific reduction targets or made formal climate pledges, which may limit their ability to effectively address their carbon footprint. The absence of documented reduction initiatives suggests a need for enhanced climate commitments in line with industry standards. Overall, while the company has made some progress in managing its emissions, particularly in Scope 1 and 2, the lack of comprehensive reduction strategies and the high levels of Scope 3 emissions highlight areas for potential improvement in their climate action efforts.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 2,929,130 | 0,000,000 | 000,000 |
| Scope 2 | 21,769,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,800,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Healthcare Global Enterprises is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
